育龄期子宫内膜异位症女性的激素治疗：最新进展
HORMONAL THERAPY IN WOMEN OF REPRODUCTIVE AGE WITH ENDOMETRIOSIS: AN UPDATE.
作者信息
Gheorghisan-Galateanu A A, Gheorghiu M L
机构信息
"Carol Davila" University of Medicine and Pharmacy - Dept. of Cellular and Molecular Biology and Histology, Bucharest, Romania.
"C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
出版信息
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):276-281. doi: 10.4183/aeb.2019.276.
Abstract
Medical therapy of endometriosis is under continuous reevaluation. Hereby we updated the drugs currently available or under investigation for the hormonal treatment of endometriosis.
摘要
子宫内膜异位症的药物治疗正在不断重新评估。在此，我们更新了目前可用于或正在研究用于子宫内膜异位症激素治疗的药物。
相似文献
1
HORMONAL THERAPY IN WOMEN OF REPRODUCTIVE AGE WITH ENDOMETRIOSIS: AN UPDATE.育龄期子宫内膜异位症女性的激素治疗：最新进展
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):276-281. doi: 10.4183/aeb.2019.276.
2
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.子宫内膜异位症的激素和生物治疗的全面综述：最新进展。
Expert Opin Biol Ther. 2019 Apr;19(4):343-360. doi: 10.1080/14712598.2019.1581761. Epub 2019 Feb 27.
3
Current and emerging treatment options for endometriosis.内异症的现有和新兴治疗选择。
Expert Opin Pharmacother. 2018 Jul;19(10):1109-1125. doi: 10.1080/14656566.2018.1494154. Epub 2018 Jul 5.
4
Innovations in conservative endometriosis treatment: an updated review.保守性子宫内膜异位症治疗的创新：最新综述
Minerva Ginecol. 2011 Jun;63(3):247-59.
5
Hormonal therapy for endometriosis: from molecular research to bedside.子宫内膜异位症的激素治疗：从分子研究到临床应用
Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:61-66. doi: 10.1016/j.ejogrb.2016.05.032. Epub 2016 May 27.
6
Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.慢性盆腔疼痛患者子宫内膜异位症的医学管理
Semin Reprod Med. 2017 Jan;35(1):38-53. doi: 10.1055/s-0036-1597308. Epub 2016 Dec 21.
7
Role of medical treatment of endometriosis.子宫内膜异位症的治疗作用。
Minerva Obstet Gynecol. 2021 Jun;73(3):304-316. doi: 10.23736/S2724-606X.21.04784-5.
8
Emerging drugs for endometriosis.子宫内膜异位症的新兴药物
Expert Opin Emerg Drugs. 2004 May;9(1):167-77. doi: 10.1517/eoed.9.1.167.32945.
9
Emerging therapy for endometriosis.子宫内膜异位症的新兴疗法。
Expert Opin Emerg Drugs. 2015 Sep;20(3):449-61. doi: 10.1517/14728214.2015.1051966. Epub 2015 Jun 11.
10
Advances in the management of endometriosis: an update for clinicians.子宫内膜异位症管理的进展：临床医生最新资讯
Hum Reprod Update. 2006 Mar-Apr;12(2):179-89. doi: 10.1093/humupd/dmi049. Epub 2005 Nov 9.
引用本文的文献
1
Spatial, temporal and demographic distribution characteristics of adenomyosis symptom clusters from the perspective of traditional Chinese medicine: a multicenter cross-sectional study in China from 2020 to 2022.从中医角度看子宫腺肌病症状群的空间、时间和人口学分布特征：2020年至2022年中国多中心横断面研究
Front Endocrinol (Lausanne). 2025 Aug 7;16:1605310. doi: 10.3389/fendo.2025.1605310. eCollection 2025.
2
Co-existence of the abdominal wall and thoracic endometriosis: case report and literature review.腹壁与胸段子宫内膜异位症并存：病例报告及文献综述
Front Med (Lausanne). 2025 May 15;12:1578435. doi: 10.3389/fmed.2025.1578435. eCollection 2025.
3
Endometriosis-like lesions induced by phthalates: new phytotherapic applications to complement traditional cares: a PNRR 2023 project.邻苯二甲酸酯诱导的子宫内膜异位症样病变：补充传统护理的新植物疗法应用：一个2023年国家复苏与韧性计划项目
BMC Complement Med Ther. 2025 May 26;25(1):188. doi: 10.1186/s12906-025-04913-y.
4
A Podcast on Patient and Physician Perspectives on the Management of Endometriosis and Relugolix Combination Therapy.一个关于患者和医生对子宫内膜异位症和瑞戈非尼联合治疗管理的观点的播客。
Adv Ther. 2024 Dec;41(12):4369-4376. doi: 10.1007/s12325-024-02970-2. Epub 2024 Oct 19.
5
Endometriosis Treatment: Role of Natural Polyphenols as Anti-Inflammatory Agents.子宫内膜异位症的治疗：天然多酚类化合物作为抗炎剂的作用。
Nutrients. 2023 Jun 30;15(13):2967. doi: 10.3390/nu15132967.
6
Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety.孕激素治疗子宫内膜异位症症状管理的疗效和安全性的Meta 分析。
BMC Womens Health. 2022 Dec 17;22(1):526. doi: 10.1186/s12905-022-02122-0.
7
Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross-Sectional Study.德国子宫内膜异位症模式的变化；2010年至2019年的患病率及治疗情况：一项回顾性横断面研究。
Int J Fertil Steril. 2022 Apr;16(2):85-89. doi: 10.22074/IJFS.2021.528397.1113. Epub 2022 May 8.
8
Protein arginine methyltransferase 5 mediates THP-1-derived macrophage activation dependent on NF-κB in endometriosis.蛋白质精氨酸甲基转移酶5介导子宫内膜异位症中依赖于核因子κB的THP-1来源巨噬细胞活化。
Exp Ther Med. 2021 Sep;22(3):1003. doi: 10.3892/etm.2021.10436. Epub 2021 Jul 15.
9
Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis.中医方剂桂枝茯苓丸治疗子宫内膜异位症。
Int J Med Sci. 2021 Apr 16;18(11):2401-2408. doi: 10.7150/ijms.55789. eCollection 2021.
10
Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives.多酚作为子宫内膜异位症的饮食治疗概念：现状与展望。
Nutrients. 2021 Apr 18;13(4):1347. doi: 10.3390/nu13041347.
本文引用的文献
1
PSYCHO-SOCIAL ASPECTS OF QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS.子宫内膜异位症女性生活质量的心理社会方面
Acta Endocrinol (Buchar). 2017 Jul-Sep;13(3):334-339. doi: 10.4183/aeb.2017.334.
2
CONTROLLED OVARIAN STIMULATION IN ENDOMETRIOSIS PATIENTS CAN BE INDIVIDUALIZED BY ANTI-MÜLLERIAN HORMONE LEVELS.子宫内膜异位症患者的控制性卵巢刺激可根据抗苗勒管激素水平进行个体化。
Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):195-202. doi: 10.4183/aeb.2017.195.
3
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.子宫内膜异位症的激素和生物治疗的全面综述：最新进展。
Expert Opin Biol Ther. 2019 Apr;19(4):343-360. doi: 10.1080/14712598.2019.1581761. Epub 2019 Feb 27.
4
Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study.绝经前妇女用巴泽多昔芬/结合雌激素对生殖内分泌和生殖道超声表现的影响：一项初步研究。
Gynecol Endocrinol. 2019 May;35(5):390-394. doi: 10.1080/09513590.2018.1559288. Epub 2019 Jan 22.
5
Hormonal contraception in women with endometriosis: a systematic review.子宫内膜异位症女性的激素避孕：一项系统评价
Eur J Contracept Reprod Health Care. 2019 Feb;24(1):61-70. doi: 10.1080/13625187.2018.1550576. Epub 2019 Jan 21.
6
Endometriosis and Female Pelvic Pain.子宫内膜异位症与女性盆腔疼痛。
Semin Reprod Med. 2018 Mar;36(2):143-151. doi: 10.1055/s-0038-1676103. Epub 2018 Dec 19.
7
Elagolix for endometriosis: all that glitters is not gold.依葫芦利用于子宫内膜异位症：并非所有闪闪发光的都是金子。
Hum Reprod. 2019 Feb 1;34(2):193-199. doi: 10.1093/humrep/dey368.
8
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.Vilaprisan（BAY 1002670）的发现：一种用于妇科治疗的高活性和选择性孕激素受体调节剂。
ChemMedChem. 2018 Nov 6;13(21):2271-2280. doi: 10.1002/cmdc.201800487.
9
The clinical relevance of progestogens in hormonal contraception: Present status and future developments.孕激素在激素避孕中的临床相关性：现状与未来发展
Oncotarget. 2018 Oct 2;9(77):34628-34638. doi: 10.18632/oncotarget.26015.
10
Management of endometriosis from diagnosis to treatment: roadmap for the future.子宫内膜异位症从诊断到治疗的管理：未来路线图。
Minerva Ginecol. 2019 Feb;71(1):54-61. doi: 10.23736/S0026-4784.18.04320-4. Epub 2018 Oct 11.
Zotero 插件